Literature DB >> 24882616

Regulatory role of microRNAs in ovarian function.

Tal Imbar1, Iris Eisenberg2.   

Abstract

MicroRNAs have recently begun to be explored in ovarian cells, uncovering their influence on fundamental ovarian features like steroidogenesis, ovulation, and curpos luteum development and function. We provide a review of the current knowledge on microRNAs, specifically relating to human ovarian cell function and microRNAs' role in the ovarian physiologic process and ovulation dysfunction. Because of microRNAs' known stability in body fluids, we enlighten also their potential use in the clinical setting as novel biomarkers for ovarian function. Future research of the role of microRNAs in physiologic and dysfunctional ovulation may offer new diagnostic and treatment strategies for infertility and other ovarian disorders.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PCOS; POF; corpus luteum; microRNA; ovulation; serum biomarkers

Mesh:

Substances:

Year:  2014        PMID: 24882616     DOI: 10.1016/j.fertnstert.2014.04.024

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  38 in total

Review 1.  MicroRNA in Ovarian Biology and Disease.

Authors:  Lynda K McGinnis; Lacey J Luense; Lane K Christenson
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-18       Impact factor: 6.915

Review 2.  Extracellular microRNA profiling in human follicular fluid: new biomarkers in female reproductive potential.

Authors:  Maryam Qasemi; Fardin Amidi
Journal:  J Assist Reprod Genet       Date:  2020-07-09       Impact factor: 3.412

3.  miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.

Authors:  Jan M McAllister; Angela X Han; Bhavi P Modi; Maria E Teves; Grace R Mavodza; Zachary L Anderson; Tsaiwei Shen; Lane K Christenson; Kellie J Archer; Jerome F Strauss
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

4.  MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.

Authors:  Kuan Jiang; Tongle Zhi; Wenhui Xu; Xiupeng Xu; Weining Wu; Tianfu Yu; Er Nie; Xu Zhou; Zhongyuan Bao; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

5.  MIR146A and ADIPOQ genetic variants are associated with birth weight in relation to gestational age: a cohort study.

Authors:  Lívia Reis Silva; Anderson Sanches Melo; Cristiana Libardi Miranda Furtado; Rui Alberto Ferriani; Karina Bezerra Salomão; Suleimy Cristina Mazin; Luiz Gonzaga Tone; Viviane Cunha Cardoso; Rosana Maria Dos Reis
Journal:  J Assist Reprod Genet       Date:  2022-06-11       Impact factor: 3.357

6.  Overexpression of miR-26b-5p regulates the cell cycle by targeting CCND2 in GC-2 cells under exposure to extremely low frequency electromagnetic fields.

Authors:  Yong Liu; Wen-Bin Liu; Kai-Jun Liu; Lin Ao; Jia Cao; Julia Li Zhong; Jin-Yi Liu
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 7.  Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment.

Authors:  Elisabet Stener-Victorin; Qiaolin Deng
Journal:  Nat Rev Endocrinol       Date:  2021-07-07       Impact factor: 43.330

8.  MicroRNA-9119 regulates cell viability of granulosa cells in polycystic ovarian syndrome via mediating Dicer expression.

Authors:  Yang Ding; Pei He; Zhiling Li
Journal:  Mol Cell Biochem       Date:  2020-01-01       Impact factor: 3.396

Review 9.  The role of miRNAs in regulating adrenal and gonadal steroidogenesis.

Authors:  Salman Azhar; Dachuan Dong; Wen-Jun Shen; Zhigang Hu; Fredric B Kraemer
Journal:  J Mol Endocrinol       Date:  2020-01       Impact factor: 5.098

10.  New biomarkers in peripheral blood of patients with ovarian cancer: high expression levels of miR-16-5p, miR-17-5p, and miR-638.

Authors:  Mukaddes Avsar Saral; Seref Bugra Tuncer; Demet Akdeniz Odemis; Ozge Sukruoglu Erdogan; Seda Kilic Erciyas; Pınar Saip; Sevda Ozel; Hulya Yazici
Journal:  Arch Gynecol Obstet       Date:  2021-08-09       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.